- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 10, 2025 | 18.43M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 13.74M sh |
| Capex | FY 2024 · Dec 31, 2023 | $1.71M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | $6.47M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $1.98M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $25.95M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $39.37M |
| Current Assets | FY 2024 · Dec 31, 2023 | $30.56M |
| Total Assets | FY 2024 · Dec 31, 2023 | $78.75M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.04 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.04 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $14.98M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $561K |
| Net Income | FY 2024 · Dec 31, 2023 | $485K |
| Operating Income | FY 2024 · Dec 31, 2023 | $756K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $16.37M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $73.37M |
| Revenue | FY 2024 · Dec 31, 2023 | $89.74M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $37.53M |